# Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation

> **NCT04172883** · NA · TERMINATED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 79 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **OTHER:** Treatment arm

## Key facts

- **NCT ID:** NCT04172883
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-01
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-07-28
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Sponsors decision to terminate the study based on the current Covid situation which is preventing completion of study milestone.
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04172883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04172883, "Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04172883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*